Anti-inflammatory treatments have failed to ameliorate the disease condition and focus has instead turned to transforming growth factor-??1 (TGFB1), since it induces many of the processes involved, including fibroblast activation and EMT. Most recently, however, a new player in this process has been described, IGF-binding protein-5 (IGFBP5).